438 related articles for article (PubMed ID: 17762660)
1. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
[TBL] [Abstract][Full Text] [Related]
2. Ventricular function and natriuretic peptides in sequentially combined models of hypertension.
Cavallero S; González GE; Seropian IM; Cerrudo CS; Matorra F; Morales C; Hertig CM; Puyó AM; Fernández BE; Gelpi RJ
Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1290-9. PubMed ID: 20139323
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
4. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
Nakagawa O; Ogawa Y; Itoh H; Suga S; Komatsu Y; Kishimoto I; Nishino K; Yoshimasa T; Nakao K
J Clin Invest; 1995 Sep; 96(3):1280-7. PubMed ID: 7657802
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.
Holmgren D; Westerlind A; Lundberg PA; Wåhlander H
Clin Physiol Funct Imaging; 2005 Sep; 25(5):263-9. PubMed ID: 16117728
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats.
de Andrade EN; Gonçalves GK; de Oliveira TH; Santos CS; Souza CL; Firmes LB; de Magalhães AC; Soares Tde J; Reis AM; Belo Nde O
Regul Pept; 2011 Feb; 167(1):149-55. PubMed ID: 21237215
[TBL] [Abstract][Full Text] [Related]
8. Rapid activation of the type B versus type A natriuretic factor gene by aortocaval shunt induced cardiac volume overload.
Lear W; Boer PH
Cardiovasc Res; 1995 May; 29(5):676-81. PubMed ID: 7606757
[TBL] [Abstract][Full Text] [Related]
9. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
10. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.
Brown LA; Nunez DJ; Wilkins MR
J Clin Invest; 1993 Dec; 92(6):2702-12. PubMed ID: 7902846
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments.
Cerrudo CS; Cavallero S; Rodríguez Fermepín M; González GE; Donato M; Kouyoumdzian NM; Gelpi RJ; Hertig CM; Choi MR; Fernández BE
Front Physiol; 2021; 12():651246. PubMed ID: 34113261
[TBL] [Abstract][Full Text] [Related]
13. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
14. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
[TBL] [Abstract][Full Text] [Related]
15. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
Jankowski M; Wang D; Mukaddam-Daher S; Gutkowska J
J Endocrinol; 2005 Jan; 184(1):209-17. PubMed ID: 15642797
[TBL] [Abstract][Full Text] [Related]
17. Increased cardiac weight in interleukin-6 transgenic mice with viral infection accompanies impaired expression of natriuretic peptide genes.
Tanaka T; Kanda T; Itoh T; Tsugawa H; Takekoshi N; Yamakawa J; Kurimoto M; Kurabayashi M
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):275-83. PubMed ID: 12889519
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide receptors in hypertrophied adult rat cardiomyocytes.
Nader L; Lahoud L; Chouery E; Aftimos G; Bois P; Farès NA
Ann Cardiol Angeiol (Paris); 2010 Feb; 59(1):20-4. PubMed ID: 19969282
[TBL] [Abstract][Full Text] [Related]
19. The role of natriuretic peptides in cardioprotection.
Nishikimi T; Maeda N; Matsuoka H
Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
